Clark, WM., Davalos, A., Goldstein, LB., Kaste, M., Leiter, L., Zivin, J., Sillesen, H., Crimmins, D., Davis, S., Dimmitt, S., Donnan, G., Frayne, J., Freilich, D., Gillies, D., Mikocki, J., Schmidauer, C., Schmidt, R., De Bleecker, J., Deceuninck, F., ... SPARCL Investigators (2004). Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study (vol 16, pg 389, 2003). Cerebrovascular Diseases, 17(1), 91-92.